Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

Abstract Aims We aimed to assess the impact of pre‐admission beta‐blocker (BB) therapy on the clinical characteristics, in‐hospital treatment and outcomes of patients with cardiogenic shock (CS). Methods All patients enrolled in the multicentre prospective Altshock‐2 registry since March 2020 with a...

詳細記述

書誌詳細

主要な著者:	Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, Altshock‐2 investigators
フォーマット:	Artigo
言語:	Inglês
出版事項:	Oxford University Press 2025-08-01
シリーズ:	ESC Heart Failure
主題:	Cardiogenic shock beta‐blockers inotropes mortality vasopressors
オンライン･アクセス:	https://doi.org/10.1002/ehf2.15322
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!